Search results

ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.

Scientists at ANSTO characterise structures with atomic detail using probes such as x-rays, electrons, neutrons and ions.

The Australian Neutron Beam Users Group (ANBUG) presented annual awards to accomplished neutron scientists at the combined ANSTO User Meeting - AUM2023 held in late November 2023.

The Australian Centre for Neutron Scattering (ACNS) is a major research facility for neutron science that comprises a suite of neutron instruments with a range of techniques for scientific investigations in physics, chemistry, materials science, medicine and environmental science among other fields.

With over 70 years of nuclear expertise, ANSTO offers expert education and training programs

ANSTO seeks candidates who are passionate about making a contribution to Australian society through supporting nuclear science and technology.

ANSTO User Meeting 2021 - Speakers

ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.

Paper on redefinition of the kilogram receives international award

ANSTO is committed to minimising the environmental impact of its activities and to implementing strategies which have a positive effect on the environment. The ANSTO Work Health Safety and Executive Committee oversees this process.

Updated results show radiation therapy using lutetium-177 improved survival in advanced prostate cancer.

Spatz neutron reflectometer becomes 15th neutron scattering instrument that is used for studies of biological materials and other soft matter.

ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.